Download Citation
Article Source:
Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself
McCrudden CM,
O’Rourke MG,
Cherry KE,
Yuen HF,
O’Rourke D,
et al.
(2015)
Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself.
PLOS ONE 10(2): e0118187.
https://doi.org/10.1371/journal.pone.0118187